PicksThatMove: www.PicksThatMove.com: "Picks that move" Alerts, November 25, 2009: FFBC, ILMN, MRGE, HGSI, QLTI and CTEL

-- November 25, 2009 First Financial Bancorp (Nasdaq: FFBC | Quote | Chart | News | PowerRating) trading at
$13.48 on a volume of 47,891 shares

In a press release on November 25, First Financial Bancorp to Pay Cash
Dividend

CINCINNATI, Nov 25, 2009 First Financial Bancorp (Nasdaq: FFBC)
announced today that the board of directors declared a quarterly cash
dividend of 10 cents per share on November 24, 2009. The dividend will
be payable January 4, 2010 to shareholders of record as of December 4,
2009.

First Financial Bancorp has paid a cash dividend every quarter since
its formation as the holding company of First Financial Bank in April
1983.

About First Financial Bancorp

First Financial Bancorp is a Cincinnati, Ohio based bank holding
company. At September 30, 2009, the company had $7.3 billion in assets,
including $4.9 billion in total loans and $5.8 billion in deposits. Its
banking subsidiary, First Financial Bank, N.A., founded in 1863,
provides consumer and commercial banking products and services, and
investment and insurance products through its retail banking center
network. Currently First Financial Bank, N.A. operates 128 banking
centers. Its strategic operating markets are located within the four
state regions of Ohio, Indiana, Kentucky and Michigan where it operates
118 banking centers. The bank's wealth management division, First
Financial Wealth Resource Group, provides investment management,
traditional trust, brokerage, private banking, and insurance services,
and had approximately $2.0 billion in assets under management at
September 30, 2009. Additional information about the company, including
its products, services, and banking locations, is available at
www.bankatfirst.com/investor.

-- November 25, 2009 Illumina, Inc. (NASDAQ:ILMN) trading at $28.62 on
a volume of 3.04M shares

In a press release on November 25, Illumina Announces $100 Million
Share Repurchase Program

SAN DIEGO, Nov 25, 2009 Illumina, Inc. (NASDAQ:ILMN) today announced
that its Board of Directors has approved a new stock repurchase
program, authorizing the company to repurchase in the aggregate up to
$100 million of its outstanding common stock. The $75 million share
repurchase program originally announced on August 24, 2009, recently
has been completed.

About Illumina

Illumina is a leading developer, manufacturer, and marketer of
next-generation life science tools and integrated systems for the large
scale analysis of genetic variation and biological function. We provide
a comprehensive line of proprietary products and services that
currently serve the sequencing, genotyping, and gene expression
markets, and we expect to enter the market for molecular diagnostics.
Our customers include leading genomic research centers, academic
institutions, agriculture and livestock companies, pharmaceutical
companies, clinical research organizations and biotechnology companies.
Our tools provide researchers around the world with the performance,
throughput, cost effectiveness and flexibility necessary to perform the
billions of genetic tests needed to extract valuable medical
information from advances in genomics and proteomics. We believe this
information will enable researchers to correlate genetic variation and
biological function that will enhance drug discovery and clinical
research, allow diseases to be detected earlier and permit better
choices of drugs for individual patients.

-- November 25, 2009 Merge Healthcare (Nasdaq:MRGE) trading at $3.17 on
a volume of 53,184 shares.

In a press release out on November 25, InSite One expands contract with
Merge Healthcare

Nov 25, 2009 Merge Healthcare (Nasdaq:MRGE) announced on Wednesday that
medical data archiving, storage and disaster-recovery solutions
provider InSite One Inc has expanded its contract with Merge to provide
a universal viewing solution for its InDex archiving services. No
financial details were disclosed.

About Merge Healthcare Incorporated

Merge Healthcare Incorporated (Merge) develops medical imaging and
information software solutions and delivers related services. The
Company's solutions are designed to automate digital imaging workflow,
which transforms the tasks associated with film-based images and paper
information into computerized processes. It sells these solutions
through two business units: Merge Fusion and Merge OEM. Merge Fusion
sells directly to hospitals, imaging centers and specialty clinics
located in the United States, sells directly and through distributors
outside the United States, and also distributes certain products
through the Internet via its Website. The Company's Merge OEM business
unit primarily sells to original equipment manufacturers (OEMs), value
added resellers (VARs) and distributors located globally. As of July
14, 2009, Merge had acquired approximately 86% interest in etrials
Worldwide, Inc. In September 2009, Merge completed the acquisition of
Confirma, Inc.

-- November 25, 2009 Human Genome Sciences, Inc. (Nasdaq: HGSI | Quote | Chart | News | PowerRating) last at
$27.85 a volume of 1.64M shares

In a press release out on November 25, Human Genome Sciences Submits
Biologics License Application to FDA for ZALBIN(TM)

ROCKVILLE, Md., Nov 25, 2009 Human Genome Sciences, Inc. (Nasdaq: HGSI)
today announced that it has submitted a Biologics License Application
(BLA) to the U.S. Food and Drug Administration (FDA) for ZALBIN(TM)
(albinterferon alfa-2b) for the treatment of chronic hepatitis C. The
BLA submission includes the results of two pivotal Phase 3 clinical
trials showing that 900-mcg albinterferon alfa-2b dosed every two weeks
met its primary endpoint of non-inferiority to peginterferon alfa-2a
(Pegasys) dosed once each week.

About Human Genome Sciences

The mission of HGS is to apply great science and great medicine to
bring innovative drugs to patients with unmet medical needs. The HGS
clinical development pipeline includes novel drugs to treat lupus,
hepatitis C, inhalation anthrax and cancer.

-- November 25, 2009 QLT Inc. (NASDAQ: QLTI | Quote | Chart | News | PowerRating) last at $4.37 on a volume
of 1.26M shares

In a press release out on November 25, QLT announces MGH litigation
settlement

VANCOUVER, Nov. 25, 2009 QLT Inc. (NASDAQ: QLTI; TSX: QLT) ("QLT" or
the "Company") today announced the settlement of its litigation with
the General Hospital Corporation, doing business as Massachusetts
General Hospital ("MGH"). Under the terms of the settlement agreement,
QLT will pay US$20.0 million to MGH as payment in full for all past and
future royalty obligations under the License Agreement between QLT and
MGH, in exchange for the dismissal with prejudice of MGH's lawsuit
against QLT pending in the Massachusetts District Court for violation
of Massachusetts General Law Chapter 93A, sections 2 and 11. As part of
the settlement, QLT and MGH have also released each other from any
claims in connection with the lawsuit and certain related matters.
Under the existing License Agreement, QLT was obligated to pay MGH a
0.5% royalty on Visudyne(R) sales in the U.S. and Canada.

About QLT

QLT Inc. is a pharmaceutical company dedicated to the development and
commercialization of innovative therapies for the eye. We are focused
on our commercial product Visudyne(R) for the treatment of wet-AMD, and
the development of drugs to be delivered in our proprietary punctal
plug devices. For more information, visit our website at www.qltinc.com.

-- November 25, 2009 City Telecom (H.K.) Ltd. (Nasdaq: CTEL | Quote | Chart | News | PowerRating) trading at
$9.96 on a volume of 56,932 shares

In a press release out on November 25, Inclusion of City Telecom Into
MSCI Hong Kong Small Cap Index

HONG KONG, Nov 25, 2009 City Telecom (H.K.) Ltd. ("City Telecom")
(HKSE:1137) (Nasdaq:CTEL) announced that the company will be included
as a constituent of the MSCI Hong Kong Small Cap Index ("Index"),
effective 30 November 2009. This inclusion signifies that City Telecom
has met global standards in terms of full company market
capitalization, free float-adjusted market capitalization and all
additional liquidity requirements.

About City Telecom/Hong Kong Broadband Network Limited

Established in 1992, City Telecom (H.K.) Limited (HKSE:1137)
(Nasdaq:CTEL) provides integrated telecommunications services in Hong
Kong. City Telecom's wholly-owned subsidiary, Hong Kong Broadband
Network Limited (HKBN), is in the process of expanding its Next
Generation Network from approximately 1.62mn to 2.0mn homes pass. HKBN
has achieved an aggregate Voice, Broadband (symmetric 25Mbps up to
1Gbps) and IP-TV services base in excess of 943,000 subscriptions.
Additional information on City Telecom can be found at
www.ctigroup.com.hk.

www.picksthatmove.com is a leading stock website that provides free
daily alerts on stocks that are moving up. www.picksthatmove.com also
tracks small cap stocks that are on the brink of exploding. We also
feature companies on our website with research report, analysis, and
newsletters. To feature a company on our web site please contact us at
Info@picksthatmove.com

www.picksthatmove.com is an independent electronic publication that
provides information on selected publicly traded companies.
www.picksthatmove.com is not a registered investment advisor or
broker-dealer. www.picksthatmove.com affiliates, officers, directors
and employees may buy and sell additional shares in any company
mentioned herein and may profit in the event those shares rise in
value. Please do your own Due Diligence before investing in any of the
stocks mentioned above.

CONTACT: PicksThatMove
e-mail: Info@picksthatmove.com
WWW: http://www.picksthatmove.com

((M2 Communications disclaims all liability for information provided
within M2 PressWIRE. Data supplied by named party/parties. Further
information on M2 PressWIRE can be obtained at http://www.presswire.net
on the world wide web. Inquiries to info@m2.com.

For full details on Merge Technologies Inc (MRGE) MRGE. Merge Technologies Inc (MRGE) has Short Term PowerRatings at TradingMarkets. Details on Merge Technologies Inc (MRGE) Short Term PowerRatings is available at This Link.

For full details on First Financl BAncorp Oh (FFBC) FFBC. First Financl BAncorp Oh (FFBC) has Short Term PowerRatings at TradingMarkets. Details on First Financl BAncorp Oh (FFBC) Short Term PowerRatings is available at This Link.

For full details on Illumina Inc (ILMN) ILMN. Illumina Inc (ILMN) has Short Term PowerRatings at TradingMarkets. Details on Illumina Inc (ILMN) Short Term PowerRatings is available at This Link.

For full details on Human Genome Sciences (HGSI) HGSI. Human Genome Sciences (HGSI) has Short Term PowerRatings at TradingMarkets. Details on Human Genome Sciences (HGSI) Short Term PowerRatings is available at This Link.

For full details on Qlt Inc (QLTI) QLTI. Qlt Inc (QLTI) has Short Term PowerRatings at TradingMarkets. Details on Qlt Inc (QLTI) Short Term PowerRatings is available at This Link.

For full details on City Telecom Hk Ltd Ads (CTEL) CTEL. City Telecom Hk Ltd Ads (CTEL) has Short Term PowerRatings at TradingMarkets. Details on City Telecom Hk Ltd Ads (CTEL) Short Term PowerRatings is available at This Link.